Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07731685 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases

Name: A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases — clinical trial record (NCT07731685)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorJiangsu vcare pharmaceutical technology co., LTD

Started2026-07-30

View on ClinicalTrials.gov ↗

Jiangsu vcare pharmaceutical technology co., LTD

17 trials monitored

See all monitored trials

This is a randomized, double-blind, placebo-controlled Phase Ib study evaluating the safety and efficacy of VC004 capsules for the relief of moderate-to-severe pain associated with bone metastases

Trial Details

NCT Number	NCT07731685
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Pain in Bone Metastases
Enrollment	26 participants
Start Date	2026-07-30
Primary Completion	2027-12-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-28